Cytogen deal with Northwest Biotherapeutics

CYTO granted an exclusive worldwide sublicense to Northwest Biotherapeutics (Seattle, Wash.) to manufacture and use prostate specific membrane antigen ( PSMA) in ex vivo prostate cancer immunotherapy....